Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection
- PMID: 17520535
- DOI: 10.1086/516798
Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection
Abstract
Objective: Many studies have investigated the association between prior antibiotic use and antibiotic resistance. However, methods used in past studies to describe the extent of prior antibiotic use (eg, use of the 2 categories exposure versus no exposure and measurement of duration of exposure) have not been reviewed. The impact of the use of different methods for quantifying the use of antibiotics is unknown. The objectives of this study were to characterize past approaches to describing the extent of antibiotic use and to identify the impact of the use of different methods on associations between use of specific antibiotics and infection with an antibiotic-resistant-organism.
Methods: We conducted a systematic review of studies that investigated risk factors for extended-spectrum beta -lactamase (ESBL)-producing Escherichia coli and Klebsiella species to identify variability in past approaches to describing the extent of antibiotic use. We then reanalyzed a data set from a prior study of risk factors for infection with ESBL-producing E. coli and Klebsiella species. We developed 2 separate multivariable models: 1 in which prior antibiotic use was described as a categorical variable (eg, exposure or no exposure) and 1 in which antibiotic use was described as a continuous variable (eg, measured in antibiotic-days). These models were compared qualitatively.
Setting: Large academic medical center.
Results: The 25 articles included in the systematic review revealed a variety of methods used to describe the extent of prior antibiotic exposure. Only 1 study justified its approach. Results from the 2 multivariable models that used different methodologic approaches differed substantially. Specifically, use of third-generation cephalosporins was a risk factor for infection with ESBL-producing E. coli and Klebsiella species when antibiotic use was described as a continuous variable but not when antibiotic use was described as a categorical variable.
Conclusions: There has been no consistent method for assessing the extent of prior antibiotic exposure. The use of different methods may substantially alter the identified antimicrobial risk factors, which has important implications for the resultant interventions regarding antimicrobial use.
Similar articles
-
Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use.Int J Antimicrob Agents. 2006 Oct;28(4):325-32. doi: 10.1016/j.ijantimicag.2006.04.014. Epub 2006 Aug 24. Int J Antimicrob Agents. 2006. PMID: 16934439 Review.
-
Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.Infect Control Hosp Epidemiol. 2008 Nov;29(11):1026-34. doi: 10.1086/591864. Infect Control Hosp Epidemiol. 2008. PMID: 18947321
-
Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.World J Urol. 2016 Jul;34(7):1031-7. doi: 10.1007/s00345-015-1718-x. Epub 2015 Oct 28. World J Urol. 2016. PMID: 26511749
-
Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.Infection. 2007 Oct;35(5):339-45. doi: 10.1007/s15010-007-6356-9. Epub 2007 Aug 25. Infection. 2007. PMID: 17721736
-
Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern.J Basic Microbiol. 2017 Jun;57(6):460-470. doi: 10.1002/jobm.201700008. Epub 2017 Apr 11. J Basic Microbiol. 2017. PMID: 28397262 Review.
Cited by
-
Can precision antibiotic prescribing help prevent the spread of carbapenem-resistant organisms in the hospital setting?JAC Antimicrob Resist. 2023 Mar 29;5(2):dlad036. doi: 10.1093/jacamr/dlad036. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 37008824 Free PMC article. Review.
-
Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART).Open Forum Infect Dis. 2022 Dec 9;9(12):ofac659. doi: 10.1093/ofid/ofac659. eCollection 2022 Dec. Open Forum Infect Dis. 2022. PMID: 36582770 Free PMC article.
-
Impact of antibiotic usage on extended-spectrum β-lactamase producing Escherichia coli prevalence.Sci Rep. 2021 Jun 22;11(1):13024. doi: 10.1038/s41598-021-91332-x. Sci Rep. 2021. PMID: 34158540 Free PMC article.
-
Prior Antibiotic Therapy and the Onset of Healthcare-Associated Infections Sustained by Multidrug-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients: A Nested Case-Control Study.Antibiotics (Basel). 2021 Mar 15;10(3):302. doi: 10.3390/antibiotics10030302. Antibiotics (Basel). 2021. PMID: 33804087 Free PMC article.
-
The Association Between the Frequency of Interruptions in Antibiotic Exposure and the Risk of Health Care-Associated Clostridiodes difficile Infection.Curr Ther Res Clin Exp. 2020 Aug 5;93:100600. doi: 10.1016/j.curtheres.2020.100600. eCollection 2020. Curr Ther Res Clin Exp. 2020. PMID: 32904045 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
